Drug · DIN 02465663
SPINRAZA
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 29, 2017; first marketed August 29, 2017.
- Drug Identification Number (DIN)
- 02465663
- Company (DIN owner)
- Biogen Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intrathecal
- Therapeutic class (ATC)
- Nusinersen M09AX07
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NUSINERSEN (NUSINERSEN SODIUM) | 2.4 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 29, 2017: NOC 19476New Drug Submission (NDS)